CapsoVision, Inc.
NASDAQ: CV0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Kang-Huai Wang
- Employees
- 99
- Headquarters
- Saratoga, United States
- IPO year
- 2025
- Market cap
- $354.2M
- Website
- https://capsovision.com
Loading CV…
Loading profile data…Frequently asked questions about CV
What does CapsoVision, Inc. (CV) do?
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visua...
Where does CV trade?
CapsoVision, Inc. (CV) trades on the NASDAQ.
What sector is CV in?
CapsoVision, Inc. (CV) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of CapsoVision, Inc.?
Kang-Huai Wang is the chief executive officer of CapsoVision, Inc. (CV).
Where is CapsoVision, Inc. headquartered?
CapsoVision, Inc. is headquartered in United States.
Does CV pay a dividend?
CapsoVision, Inc. (CV) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did CV go public?
CapsoVision, Inc. (CV) completed its initial public offering in 2025.